Showing results (411-420 of 1,014) with videos related to
Sort By:
Pageof 102
Pediatric Neurology|November 1, 1995
Generalized chorea in an infant with semilobar holoprosencephalyE D Louis, T Lynch, A L Cargan, et al.The Laryngoscope|June 1, 1988
Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 casesA Blitzer, M F Brin, S Fahn, et al.Brain Research|October 28, 1982
Chlorpromazine methiodide-induced barrel rotation: an antimuscarinic effectR E Burke, S Fahn, H R Wagner, et al.Neuropharmacology|March 1, 1984
Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brainD H Jiang, A Reches, H R Wagner, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1995
Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's diseaseO Bandmann, M B Davis, C D Marsden, et al.Brain : a Journal of Neurology|September 1, 1977
The effect of lesions of the sensorimotor cortex and the capsular pathways on servo responses from the human long thumb flexorC D Marsden, P A Merton, H B Morton, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
The syndrome of painful legs and moving toesD Dressler, P D Thompson, R F Gledhill, et al.Biochemical Pharmacology|September 1, 1983
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intakeK Murugaiah, S Fleminger, A Theodorou, et al.Acta Neurologica Scandinavica|December 1, 1980
Lisuride in the treatment of ParkinsonismM Schachter, M P Sheehy, J D Parkes, et al.European Journal of Pharmacology|December 30, 1996
Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neurolepticsM J Hurley, C M Stubbs, P Jenner, et al.Pageof 102